Amarin | AMRN - Trade Debtors

Stock Price
14.32
Daily Change
0.23 1.63%
Monthly
4.60%
Yearly
25.26%
Q1 Forecast
14.47

Amarin reported $127.31M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Alnylam Pharmaceuticals USD 964.77M 397.66M Sep/2025
Amarin USD 127.31M 8.18M Sep/2025
AstraZeneca USD 17.56B 1.32B Sep/2025
DBV Technologies USD 15.97M 279K Sep/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Halozyme Therapeutics USD 346.04M 29.7M Sep/2025
Ionis Pharmaceuticals USD 24.61M 27.97M Sep/2025
Neurocrine Biosciences USD 728M 132.3M Sep/2025
Novartis USD 8.98B 192M Sep/2025